MedPath

Oral Nutrition Supplementation in Hospitalized Patients

Not Applicable
Completed
Conditions
Malnutrition
Interventions
Dietary Supplement: Ensure
Registration Number
NCT02624752
Lead Sponsor
Lawson Health Research Institute
Brief Summary

The purpose of this pilot study is to determine the effect of 3 months use of enhanced Oral Nutritional Supplement (ONS) on physical function and functional performance in malnourished elderly patients.

Detailed Description

The purpose of this pilot study is to determine the effect of 3 months use of enhanced Oral Nutritional Supplementation (ONS) on muscle accretion and functional performance in malnourished elderly patients. The objectives of this study are to determine feasibility of recruitment, adherence to intervention and retention of the sample, as well as the capacity of subjects to complete functional and muscle mass measures for a planned multi-centre Randomized Controlled Trial (RCT).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • admitted to a general medical ward and recruited within 48 hours
  • over the age of 65 years
  • malnourished (subjective global assessment categories B or C patients)
Read More
Exclusion Criteria
  • have an allergy or intolerance to any component of the oral supplement
  • are designated palliative care
  • are currently suffering from refeeding syndrome
  • have a pre-existing medical condition that prevents oral intake of full fluids,
  • have an expected length of stay of less than 48 hours from the time of assessment
  • have suspected ischemic stroke as cause for admission
  • reside in a residential care home
  • are unable to walk prior to current illness.
  • are pregnant/breastfeeding
  • have a current diagnosis of diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EnsureEnsurePatients randomized to Enhanced Oral Nutritional Supplementation (ONS) will receive the standard of care hospital menu (3 meals and snacks per day) plus 2 cans of Ensure (or similar product) per day while in hospital and will continue 2 cans per day of Ensure when discharged home until they have been receiving the enhanced ONS for a total of 90 days.
Primary Outcome Measures
NameTimeMethod
Hospital Readmission Rate90 days

The number of participants who are re-admitted to hospital within 90 days of randomization. This healthcare utilization outcome will be used to determine the cost-benefit of enhanced Oral Nutritional Supplementation.

Secondary Outcome Measures
NameTimeMethod
Successful recruitment1 year

We will view this pilot study as demonstrating feasibility of recruitment if we are able to recruit 60 patients over twelve months (approximately 5 patients per month for the overall study).

Adherence to treatment90 days

Adherence to the study treatments will be defined as ≥85% of patients were given the allocated intervention. Preliminary estimates of non-administration of the trial intervention are needed, along with strategies that maximize exposure to the intervention.

Trial Locations

Locations (1)

LHSC-University Hospital

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath